Qu Li-Shuai, Liu Jin-Xia, Liu Tao-Tao, Shen Xi-Zhong, Chen Tao-Yang, Ni Zheng-Pin, Lu Cui-Hua
Department of Gastroenterology, Affiliated Hospital of Nantong University, Jiangsu Province, China.
Department of Gastroenterology, Zhongshan Hospital, Fudan University, Shanghai, China.
PLoS One. 2014 May 21;9(5):e98257. doi: 10.1371/journal.pone.0098257. eCollection 2014.
BACKGROUND/AIM: To investigate the roles of mutations in pre-S and S regions of hepatitis B virus (HBV) on the progression of hepatocellular carcinoma (HCC) in Qidong, China.
We conducted an age matched case-control study within a cohort of 2387 male HBV carriers who were recruited from August, 1996. The HBV DNA sequence in pre-S/S regions was successfully determined in 96 HCC cases and 97 control subjects. In addition, a consecutive series of samples from 11 HCC cases were employed to evaluate the pre-S deletion patterns before and after the occurrence of HCC.
After adjustment for age, history of cigarette smoking and alcohol consumption, HBeAg positivity, pre-S deletions, pre-S2 start codon mutations, and T53C mutation were significantly associated with HCC, showing adjusted odds ratios (ORs) from 1.914 to 3.199. HCC patients also had a lower frequency of T31C mutation in pre-S2 gene, compared with control subjects (0.524; 95% CI 0.280-0.982). HBV pre-S deletions were clustered mainly in the 5' end of pre-S2 region. Multivariate analysis showed that pre-S deletions and pre-S2 start codon mutations were independent risk factors for HCC. The OR (95% CI) were 2.434 (1.063-5.573) and 3.065 (1.099-8.547), respectively. The longitudinal observation indicated that the pre-S deletion mutations were not acquired at the beginning of HBV infection, but that the mutations occurred during the long course of liver disease.
Pre-S deletions and pre-S2 start codon mutations were independently associated with the development of HCC. The results also provided direct evidence that pre-S deletion mutations were not acquired from the beginning of infection but arose de novo during the progression of liver disease.
背景/目的:研究中国启东地区乙型肝炎病毒(HBV)前S区和S区突变在肝细胞癌(HCC)进展中的作用。
我们在1996年8月招募的2387名男性HBV携带者队列中进行了一项年龄匹配的病例对照研究。成功测定了96例HCC病例和97例对照受试者前S/S区的HBV DNA序列。此外,采用11例HCC病例的连续系列样本评估HCC发生前后的前S缺失模式。
在调整年龄、吸烟史、饮酒史、HBeAg阳性、前S缺失、前S2起始密码子突变和T53C突变后,这些因素与HCC显著相关,调整后的比值比(OR)为1.914至3.199。与对照受试者相比,HCC患者前S2基因中T31C突变的频率也较低(0.524;95%可信区间0.280 - 0.982)。HBV前S缺失主要聚集在前S2区的5'端。多变量分析表明,前S缺失和前S2起始密码子突变是HCC的独立危险因素。OR(95%可信区间)分别为2.434(1.063 - 5.573)和3.065(1.099 - 8.547)。纵向观察表明,前S缺失突变不是在HBV感染开始时获得的,而是在肝病的漫长病程中发生的。
前S缺失和前S2起始密码子突变与HCC的发生独立相关。结果还提供了直接证据,表明前S缺失突变不是从感染开始时获得的,而是在肝病进展过程中从头发生的。